Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladislav Prikler

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Problems with prostate-specific antigen screening: a critical reviewHans-Peter Schmid, Ladislav Prikler, Axel Semjonow
Critical Reviews in Oncology/Hematology|April 20, 2004
Update on screening for prostate cancer with prostate-specific antigenHans-Peter Schmid, Walter Riesen, Ladislav Prikler
Urologia Internationalis|October 13, 2006
Intermittent ureteral herniation--rare cause of flank painWaltraud M Remmele, Ladislav Prikler, Hans-Peter Schmid, et al.
Blood|November 1, 2003
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2Elke Scandella, Ying Men, Daniel F Legler, et al.
European Journal of Radiology|July 20, 2010
High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV techniqueCarolin Reischauer, Bertram J Wilm, Johannes M Froehlich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2009
Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimetersHans Schiefer, Friedrich von Toggenburg, Wolf Seelentag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 24, 2015
PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticatorDaniel S Engeler, Christoph Schwab, Armin F Thöni, et al.
BJU International|January 23, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registryPascal Viktorin-Baier, Paul M Putora, Hans-Peter Schmid, et al.
European Urology Open Science|December 19, 2024
Predicting Urinary Function Outcomes Following Low-dose-rate Brachytherapy for Prostate CancerGianni Rüedi, Manolis Pratsinis, Hans-Peter Schmid, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Problems with prostate-specific antigen screening: a critical reviewHans-Peter Schmid, Ladislav Prikler, Axel Semjonow
Critical Reviews in Oncology/Hematology|April 20, 2004
Update on screening for prostate cancer with prostate-specific antigenHans-Peter Schmid, Walter Riesen, Ladislav Prikler
Urologia Internationalis|October 13, 2006
Intermittent ureteral herniation--rare cause of flank painWaltraud M Remmele, Ladislav Prikler, Hans-Peter Schmid, et al.
Blood|November 1, 2003
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2Elke Scandella, Ying Men, Daniel F Legler, et al.
European Journal of Radiology|July 20, 2010
High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV techniqueCarolin Reischauer, Bertram J Wilm, Johannes M Froehlich, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 7, 2009
Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimetersHans Schiefer, Friedrich von Toggenburg, Wolf Seelentag, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 24, 2015
PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticatorDaniel S Engeler, Christoph Schwab, Armin F Thöni, et al.
BJU International|January 23, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registryPascal Viktorin-Baier, Paul M Putora, Hans-Peter Schmid, et al.
European Urology Open Science|December 19, 2024
Predicting Urinary Function Outcomes Following Low-dose-rate Brachytherapy for Prostate CancerGianni Rüedi, Manolis Pratsinis, Hans-Peter Schmid, et al.
Pageof 1